Drucken - Print

Clinic for Bone Marrow Transplants

Prof. Dr. med. Dietrich W. Beelen


Prof. Dr. med. Dietrich W. Beelen




Ulrike Krumpf


+49 (0) 201-723-31 36


+49 (0) 201-723-59 61



Deputy Director:

Dr. med. Rudolf Trenschel


Facts and Figures

Allogeneic primary transplants; including pediatric patients: 176

Autologous transplants; including pediatric patients: 14

Patients with myeloid leukemia: approximately 100

Patients with lymphatic leukemia: approximately 50


Focus areas

Focus areas of inpatient treatment are allogeneic stem cell transplants to treat both malignant and benign hematologic systemic diseases and the transplanting of a patient's own bloodforming stem cells after myoablative (i.e., irreversibly wiping out bone marrow function) or intensity reduced prior therapy.

The clinic is particularly experienced in allogeneic stem cell transplants with partially tissue compatible donors who are or are not related to the recipient. These transplants now constitute the majority (70%) of all transplant donations carried out at the clinic.

The clinic has its own area for the production of stem cell preparations. The clinic's coordinating center facilitates the communication among patients, donors, donor registry, and referring institutions, and also coordinates all organizational processes involved in stem cell transplants.


Special consultations

Outpatient clinic of the Clinic for Bone Marrow Transplants


Fields of Research

  • Multicenter studies on the optimization of treatments for leukemia, lymphoma, and multiple myeloma
  • Development and trials of new methods in conditioning therapy (including new cytostatics, radioimmune therapy, helical tomotherapy)
  • Allogeneic stem cell transplants in older patients
  • Allogeneic stem cell transplants with partially identical donors
  • Optimization of donor selection
  • Methods of transplant modification
  • Adoptive cell therapy following allogeneic stem cell transplants
  • Importance of molecular polymorphisms of congenital and acquired immunity in allogeneic stem cell transplants
  • Detection and therapy of molecular residual disease following allogeneic stem cell transplants


Number of patients

Inpatient: 320

Outpatient: 6,530



There are 14 physicians at the clinic, including 8 specialists in hematology, oncology, immunology, endocrinology, diabetology, and gastroenterology.

In addition, there are 58 nurses, 31% of whom have advanced specialized training in the clinic's fields.